A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

Fintel reports that on December 12, 2025, Jefferies initiated coverage of Moderna (NasdaqGS:MRNA) with a Hold recommendation. Analyst Price Forecast Suggests 29.18% Upside As of December 5, 2025, the ...

The S&P 500 Healthcare sector (XLV) experienced a rise in average short interest during November, moving from 1.97% to 2.12%.

FDA plans possible black box warning for COVID-19 shots amid rare heart risk reports; studies say the virus carries a higher ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

A new national cohort study published in JAMA provides one of the most extensive looks to date at long-term mortality after ...

The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...